Pricing Log in Create free account

Curis, Inc. (CRIS) vs ZyVersa Therapeutics, Inc. (ZVSA)

Curis, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. Curis, Inc. and ZyVersa Therapeutics, Inc. are of similar size ($1.1M and $970.0K). Across the 8 metrics below, Curis, Inc. leads on 5 and ZyVersa Therapeutics, Inc. on 3.

Valuation

Metric CRIS ZVSA Biotechnology median
P/E n/m n/m 8.50
P/S 0.09 n/m 9.71
P/B 0.19 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales (0.37) n/m 9.21
Earnings yield (3,468.29%) (7,359.20%) (33.15%)
Free cash flow yield (3,540.29%) (1,023.07%) (25.50%)

Profitability

Metric CRIS ZVSA Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% 817.13% (56.36%)
Return on assets (87.76%) (225.42%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS ZVSA Biotechnology median
Revenue growth (TTM) (13.43%) — 6.02%
EPS growth (last fiscal year) 91.57% 50.71% 30.26%
Revenue growth, 5-year CAGR (2.71%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 0.05 4.72
Net debt to EBITDA 0.91 0.00 0.96

Dividend

Metric CRIS ZVSA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRIS ZVSA Biotechnology median
Market cap 1.06m 970.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack